TP53 and neoplasm: These observations were reinforced by Gene Ontology analysis of shared and unique DEGs for the distinct tumor genotypes, which highlighted a relative depletion of p53 signatures in MYC-p53−/− tumors and enrichment of immune-related pathways in MSI tumors (Extended Data Fig. 7a–f and Supplementary Tables 6–19).